Tekmira Pharmaceuticals Corporation Cash Conversion Cycle
Tekmira Pharmaceuticals Corporation Cash Conversion Cycle Chart
View Cash Conversion Cycle for TKMR.
Start Your YCharts Pro Gold Membership.
Tekmira Pharmaceuticals Corporation Historical Cash Conversion Cycle Data
Pro Data ExportThere is no data for the selected date range.
About Cash Conversion Cycle
The cash conversion cycle (CCC) is the theoretical amount of time between a company spending cash and receiving cash per each sale, output, unit of operation, etc. It is basically a measure of how long cash is tied up in working capital.
See a sample analysis using the cash conversion cycle.
Learn More
View Cash Conversion Cycle for TKMR.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
TKMR Cash Conversion Cycle Benchmarks
| Companies | |
|---|---|
| Alnylam Pharmaceuticals | Go Pro |
| DelMar Pharmaceuticals | Go Pro |
| Arqule | Go Pro |
TKMR Cash Conversion Cycle Rankings
| Overall |
80th percentile 1460 of 7590 |
| Sector |
82nd percentile 116 of 651 in Healthcare |
| Industry |
84th percentile 37 of 238 in Biotechnology |
TKMR Cash Conversion Cycle Range, Past 5 Years
| Minimum | Go Pro | Sep 2010 |
| Maximum | Go Pro | Mar 2011 |
| Average | Go Pro |
TKMR News
Seeking Alpha May 14